Diabetes mellitus and coronary heart disease

American Journal of Kidney Diseases

Volumn 32, Issue 5 SUPPL. 3, 1998, Pages

  Wilson, Peter W F ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Coronary heart disease; Diabetes

Indexed keywords

ANGINA PECTORIS; BLOOD PRESSURE REGULATION; CORONARY RISK; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; REVIEW; RISK FACTOR; UNITED STATES;

EID: 0031764798     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v32.pm9820468     Document Type: Article

References (115)

1. Higgins M, Thom TJ: Trends in CHD in the United States. Int J Epidemiol 18:S58-S66, 1989
2. Grundy SM: Cholesterol and coronary heart disease. The 21st century. Arch Intern Med 157:1177-1184, 1997
3. Harris MI, Hadden WC, Knowler WC, Bennett PH: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. Population aged 20-74 yr. Diabetes 36:523-534, 1987
4. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
5. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
6. Samos LF, Roos BA: Diabetes mellitus in older persons. Med Clin North Am 82:791-803, 1998
7. Atkinson MA, Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331: 1428-1436, 1994
8. King H, Rewers M: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 16:157-177, 1993
9. Kenny SJ, Aubert RE, Geiss LS: Prevalence and incidence of non-insulin-dependent diabetes, in Harris MI (ed): Diabetes in America (ed 2). Bethesda, MD, National Institutes of Health, 1995, pp 47-68
10. Rewers M, Shetterly SM, Baxter J, Marshall JA, Hamman RF: Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol 135:1321-1330, 1992
11. Palumbo PJ, Elveback LR, Chu CP, Connolly DC, Kurland LT: Diabetes mellitus: Incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota, 1945-1970. Diabetes 25:566-573, 1976
12. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 265:627-632, 1991
13. Wingard DL, Barrett-Connor EL: Heart disease and diabetes, in Harris MI (ed): Diabetes in America (ed 2). Bethesda, MD, National Institutes of Health, 1995, pp 429-448
14. Goodkin G: Mortality factors in diabetes. A 20 year mortality study. J Occup Med 17:716-721, 1975
15. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59:750-755, 1987
16. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Ellis D, LaPorte RE, Kuller LH, Wolfson SK Jr, Drash AL: Factors associated with avoidance of severe complications after 25 years of IDDM: Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care 13:741-747, 1990
17. Krolewski AS, Warram JH, Rand LI, Kahn CR: Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317:1390-1398, 1987
18. Bale GS, Entmacher PS: Estimated life expectancy of diabetics. Diabetes 26:434-438, 1977
19. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: The Framingham Study. Circulation 59:8-13, 1979
20. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabetes Care 2:120-126, 1979
21. Kannel WB, Abbott RD: Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham Study. N Engl J Med 311:1144-1147, 1984
22. Scheidt-Nave C, Barrett-Connor E, Wingard DL: Resting electrocardiographic abnormalities suggestive of asymptomatic ischemic heart disease associated with non-insulin-dependent diabetes mellitus in a defined population. Circulation 81:899-906, 1990
23. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E, Leland OS, Jr.: Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med 108:170-175, 1988
24. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW: Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 67:1073-1078, 1991
25. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD: Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 91:635-640, 1995
26. Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S, Kereiakes DJ, Topol EJ: Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol 21:920-925, 1993
27. Herlitz J, Malmberg K, Karlson BW, Ryden L, Hjalmarson A: Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med Scand 224:31-38, 1988
28. Woods KL, Samanta A, Burden AC: Diabetes mellitus as a risk factor for acute myocardial infarction in Asians and Europeans. Br Heart J 62:118-122, 1989
29. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss HW, Willerson JT, Robertson T: The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol 14:49-57, 1989
30. Hands ME, Rutherford JD, Muller JE, Davies G, Stone PH, Parker C, Braunwald E: The in-hospital development of cardiogenic shock after myocardial infarction: Incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol 14:40-46; discussion 47-48, 1989
31. Weitzman S, Wagner GS, Heiss G, Haney TL, Slome C: Myocardial infarction site and mortality in diabetes. Diabetes Care 5:31-35, 1982
32. Ulvenstam G, Aberg A, Bergstrand R, Johansson S, Pennert K, Vedin A, Wilhelmsen L, Wilhelmsson C: Long-term prognosis after myocardial infarction in men with diabetes. Diabetes 34:787-792, 1985
33. Abbott RD, Donahue RP, Kannel WB, Wilson PWF: The impact of diabetes on survival following myocardial infarction in men versus women: The Framingham Study. JAMA 260:3456-3460, 1988
34. Gundersen T, Kjekshus J: Timolol treatment after myocardial infarction in diabetic patients. Diabetes Care 6:285-290, 1983
35. Pedersen TR: Six-year follow-up of the Norwegian Multicenter Study on timolol after acute myocardial infarction. N Engl J Med 313:1055-1058, 1985
36. Burchfiel CM, Reed DM, Marcus EB, Strong JP, Hayashi T: Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions. An autopsy study from the Honolulu Heart Program. Am J Epidemiol 137: 1328-1340, 1993
37. Yarom R, Zirkin H, Stammler G, Rose AG: Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material. J Pathol 166:265-270, 1992
38. Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL, Grosswald R, Liberman HA, Douglas JS Jr, Morris DC, King SB: Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 91:979-989, 1995
39. Lawrie GM, Morris GC Jr, Glaeser DH: Influence of diabetes mellitus on the results of coronary bypass surgery. Follow-up of 212 diabetic patients ten to 15 years after surgery. JAMA 256:2967-2971, 1986
40. Schaff HV, Rosen AD, Shemin RJ, Leclerc Y, Wareing TH, Aguirre FV, Sopko G, VanderSalm TJ, Loop FD: Clinical and operative characteristics of patients randomized to coronary artery bypass surgery in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol 75: 18C-26C, 1995
41. Kannel WB, Hjortland MC, Castelli WP: Role of diabetes in congestive heart failure. The Framingham Study. Am J Cardiol 34:29-34, 1974
42. Schaffer SW: Cardiomyopathy associated with noninsulin-dependent diabetes. Mol Cell Biochem 107:1-20, 1991
43. Zarich SW, Nesto RW: Diabetic cardiomyopathy. Am Heart J 118:1000-1012, 1989
44. Bouchard A, Sanz N, Botvinick EH, Phillips N, Heilbron D, Byrd BF, Karam JH, Schiller NB: Noninvasive assessment of cardiomyopathy in normotensive diabetic patients between 20 and 50 years old. Am J Med 87: 160-166, 1989
45. Galderisi M, Anderson KM, Wilson PWF, Levy D: Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study). Am J Cardiol 68:85-89, 1991
46. Mustonen JN, Uusitupa MI, Laakso M, Vanninen E, Lansimies E, Kuikka JT, Pyorala K: Left ventricular systolic function in middle-aged patients with diabetes mellitus. Am J Cardiol 73:1202-1208, 1994
47. Sasson Z, Rasooly Y, Bhesania T, Rasooly I: Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 88:1431-1436, 1993
48. Reid DD, Hamilton PJS, McCartney P: Smoking and other risk factors for coronary heart-disease in British civil servants. Lancet 2:979-984, 1976
49. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669-677, 1992
50. Schneider JF, Thomas HE Jr, Sorlie PD, Kreger BE, McNamara PM, Kannel WB: Comparative features of newly acquired left and right bundle branch block in the general population: The Framingham Study. Am J Cardiol 47:931-940, 1981
51. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840-844, 1994
52. Straub RH, Thum M, Hollerbach C, Palitzsch KD, Scholmerich J: Impact of obesity on neuropathic late complications in NIDDM. Diabetes Care 17:1290-1294, 1994
53. Consensus Statement: Standardized measures in diabetic neuropathy. Diabetes Care 19:S72-S92, 1996 (suppl 1)
54. Ewing DJ, Borsey DQ, Travis P, Bellavere F, Neilson JMM, Clarke BF: Abnormalites of ambulatory 24-hour heart rate in diabetes mellitus. Diabetes 32:101-105, 1983
55. Ewing DJ, Campbell IW, Clarke BF: The natural history of diabetic autonomie neuropathy. Q J Med 49: 95-108, 1980
56. Skyler JS: The UGDP and insulin therapy. Diabetes Care 1:328-329, 1978 (editorial)
57. Anonymous: American diabetes association policy statement: The UGDP controversy. Diabetes Care 2:1-3, 1979
58. Genuth S: Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus. Ann Intern Med 124:104-109, 1996
59. Knatterud GL, Klimt CR, Levin ME, Jacobson ME, Goldner MG: Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment. JAMA 240:37-42, 1978
60. Nathan DM, Singer DE, Hurxthal K, Goodson JD: The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 310:341-346, 1984
61. Orchard TJ: From diagnosis and classification to complications and therapy. Part II. Diabetes Control and Complications Trial. Diabetes Care 17:326-338, 1994
62. Laakso M: Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus: The Finnish Studies. Ann Intern Med 124:127-130, 1996
63. Kuusisto J, Mykkanen L, Pyorala K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960-967, 1994
64. Godine JE: The relationship between metabolic control and vascular complications of diabetes mellitus. Med Clin North Am 72:1271-1284, 1988
65. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986, 1993
66. The Diabetes Control and Complications Trial (DCCT) Research Group: Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 75:894-903, 1995
67. Colwell JA: The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus: Implications of the Veterans Affairs Cooperative Study on glycemic control and complications in NIDDM. Ann Intern Med 124:131-135, 1996
68. Turner R, Cull C, Holman R: United Kingdom prospective diabetes study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 124:136-145, 1996
69. Henry RR, Genuth S: Forum One: Current recommen dations about intensification of metabolic control in non-insulin-dependent diabetes mellitus. Ann Intern Med 124: 175-177, 1996
70. Consensus Statement: The pharmacological treatment of hyperglycemia in NIDDM. Diabetes Care 19: S54-S61, 1996 (suppl 1)
71. Perriello G, Misericordia P, Volpi E, Santucci A, Santucci C, Ferrannini E, Ventura MM, Santeusanio F, Brunetti P, Bolli GB: Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes 43:920-928, 1994
72. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 20:S5-S13, 1997
73. Wilson PWF, Anderson KM, Kannel WB: The epidemiology of diabetes mellitus in the elderly: The Framingham Study. Am J Med 80:3-9, 1986
74. Nielsen FS, Rossing P, Bang LE, Svendsen TL, Gall MA, Smidt UM, Parving HH: On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 44:783-789, 1995
75. Parving HH, Rossing P: Calcium antagonists and the diabetic hypertensive patient. Am J Kidney Dis 21:47-52, 1993
76. Consensus Statement: Diagnosis and management of nephropathy in patients with diabetes mellitus. Ann Intern Med 19:8103-8106, 1996 (suppl 1)
77. Mogensen CE, Christensen CK, Vittinghus E: The stages in diabetic renal disease: With emphasis on the stage of incipient diabetic nephropathy. Diabetes 32:64-78, 1983 (suppl 2)
78. Rossing P, Rossing K, Jacobsen P, Parving HH: Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 44:739-743, 1995
79. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, Steifes MW, Striker PJ, Viberti GC: Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346:1080-1084, 1995
80. Consensus Statement: Treatment of hypertension in diabetes. Diabetes Care 19:S107-S113, 1996 (suppl 1)
81. Parving HH, Gall MA, Nielsen FS: Dyslipidaemia and cardiovascular disease in non-insulin-dependent diabetic patient with and without diabetic nephropathy. J Intern Med Suppl 736:89-94, 1994
82. Anonymous: The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure [see comments]. Arch Intern Med 157:2413-2446, 1997
83. Howard BV, Lee ET, Cowan LD, Fabsitz RR, Howard WJ, Oopik AJ, Robbins DC, Savage PJ, Yeh JL, Welty TK: Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. Am J Epidemiol 142:254-268, 1995
84. Laakso M, Ronnemaa T, Pyorala K, Kallio V, Puska P, Penttila I: Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 11:449-463, 1988
85. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed pre-diabetic individuals: Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893-2898, 1990
86. Cowie CC, Harris MI: Physical and metabolic characteristics of persons with diabetes, in Harris MI (ed): Diabetes in America (ed 2). Bethesda, MD, National Institutes of Health, 1995, pp 117-164
87. Harris MI: Hypercholesterolemia in diabetes and glucose intolerance in the US population. Diabetes Care 14: 366-374, 1991
88. Howard BV: Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613-628, 1987
89. Haffner SM, Tuttle KR, Rainwater DL: Decrease of Lp(a) with improved glycemic control in subjects with insulin-dependent diabetes mellitus. Diabetes Care 14: 302-307, 1991
90. Haffner SM: Lipoprotein(a) and diabetes. An update. Diabetes Care 16:835-840, 1993
91. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104, 1982
92. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM: Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917-1921, 1988
93. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ: Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12:187-195, 1992
94. McNamara JR, Jenner JL, Li Z, Wilson PW, Schaefer EJ: Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 12: 1284-1290, 1992
95. Koskinen P, Manttari M, Manninen V, Huttunen JK, Heinonen OP, Frick MH: Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 15:820-825, 1992
96. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) [see comments] [published erratum appears in Diabetes Care 20:1048, 1997]. Diabetes Care 20:614-620, 1997
97. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335:1001-1009, 1996
98. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults: Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 269:3015-3023, 1993
99. Podgor MJ, Kannel WB, Cassel GH, Sperduto RD: Lens changes and the incidence of cardiovascular events among persons with diabetes. Am Heart J 117:642-648, 1989
100. Killer R, Sperduto RD, Podgor MJ, Ferris FLI, Wilson PWF: Diabetic retinopathy and cardiovascular disease in type II diabetics. The Framingham Heart Study and the Framingham Eye Study. Am J Epidemiol 128:402-409, 1988
101. Kannel WB, D'Agostino RB, Wilson PWF, Belanger AJ, Gagnon DR: Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience. Am Heart J 120:672-676, 1990
102. Kannel WB, Wolf R, Castelli WP, D'Agostino RB: Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 258:1183-1186, 1987
103. Sowers JR, Standley PR, Ram JL, Jocober S, Simpson L, Rose K: Hyperinsulinemia, insulin resistance, and hyperglycemia: Contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens 6:260S-270S, 1993
104. Eldwood PC, Beswick AD, Sharp DS, Yarnell JW, Rogers S, Renaud S: Whole blood impedance platelet aggregometry and ischemic heart disease. The Caerphilly Collaborative Heart Disease Study. Arteriosclerosis 10:1032-1036, 1990
105. Colwell JA, Halushka PV, Sarji K, Levine J, Sagel J, Nair RMG: Altered platelet function in diabetes mellitus. Diabetes 25:826-831, 1976 (suppl 2)
106. Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med 118:956-963, 1993
107. Folsom AR, Wu KK, Shahar E, Davis CE: Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Arterioscler Thromb 13:1829-1836, 1993
108. Yudkin JS: Coronary heart disease in diabetes mellitus: three new risk factors and a unifying hypothesis. J Intern Med 238:21-30, 1995
109. Davi G, Averna M, Catalano I, Barbagallo CM, Giovenco E, Carroccio A, Notarbartolo A, Strano A: Platelet function in patients with type 2 diabetes mellitus: The effect of glycaemic control. Diabetes Res 10:7-12, 1989
110. Anderson KM, Wilson PWF, Odell PM, Kannel WB: An updated coronary risk profile. A statement for health professionals. Circulation 83:357-363, 1991
111. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
112. Savage PJ: Cardiovascular complications of diabetes mellitus: What we know and what we need to know about their prevention? Ann Intern Med 124:123-126, 1996
113. Geiss LS, Herman WH, Smith PJ: Mortality in non-insulin-dependent diabetes, in Harris MI (ed): Diabetes in America (ed 2). Bethesda, MD, National Institutes of Health, 1995, pp 233-25
114. Kannel WB, Wolf PA, Garrison RJ: Section 34: Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study, 30-year follow up. Springfield, VA, National Technical Information Service, 1987, pp 1-459
115. American Diabetes Association: Management of dyslipidemia in adults with diabetes. Diabetes Care 21:836-S39, 1998 (suppl 1)